TR200003521T2 - Yeniden-kombine-edilen insan interferonu beta-1a (IFN-beta-1a) formülasyonu. - Google Patents

Yeniden-kombine-edilen insan interferonu beta-1a (IFN-beta-1a) formülasyonu.

Info

Publication number
TR200003521T2
TR200003521T2 TR2000/03521T TR200003521T TR200003521T2 TR 200003521 T2 TR200003521 T2 TR 200003521T2 TR 2000/03521 T TR2000/03521 T TR 2000/03521T TR 200003521 T TR200003521 T TR 200003521T TR 200003521 T2 TR200003521 T2 TR 200003521T2
Authority
TR
Turkey
Prior art keywords
beta
ifn
formulation
human interferon
combined human
Prior art date
Application number
TR2000/03521T
Other languages
English (en)
Inventor
Alam John
Rogge Mark
Goelz Susan
Original Assignee
Biogen, Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen, Inc filed Critical Biogen, Inc
Publication of TR200003521T2 publication Critical patent/TR200003521T2/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/215IFN-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Bulus, yaklasik pH 7.2 degerinde tampon, yeniden-kombine-edilen interferon-beta ve 15 mg/ml insan serum albumini içeren sivi bilesimleri ve sözü geçen bilesimlerin parenteral kullanimi için kullanma takimlarini saglamaktadir.
TR2000/03521T 1998-05-29 1998-05-29 Yeniden-kombine-edilen insan interferonu beta-1a (IFN-beta-1a) formülasyonu. TR200003521T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/007242 WO1999062542A1 (en) 1998-05-29 1998-05-29 Recombinant human interferon beta-1a (ifn-beta-1a) formulation

Publications (1)

Publication Number Publication Date
TR200003521T2 true TR200003521T2 (tr) 2001-07-23

Family

ID=22266817

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03521T TR200003521T2 (tr) 1998-05-29 1998-05-29 Yeniden-kombine-edilen insan interferonu beta-1a (IFN-beta-1a) formülasyonu.

Country Status (16)

Country Link
EP (1) EP1082132A1 (tr)
JP (1) JP2002516874A (tr)
KR (1) KR20010052454A (tr)
CN (1) CN1299285A (tr)
AU (1) AU8822598A (tr)
BR (1) BR9815966A (tr)
CA (1) CA2333063A1 (tr)
EA (1) EA200001252A1 (tr)
EE (1) EE200000694A (tr)
HU (1) HUP0102241A2 (tr)
IL (1) IL139933A0 (tr)
IS (1) IS5732A (tr)
NO (1) NO20006022L (tr)
SK (1) SK17762000A3 (tr)
TR (1) TR200003521T2 (tr)
WO (1) WO1999062542A1 (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020025304A1 (en) * 2000-06-16 2002-02-28 Croze Edward M. Novel interferon for the treatment of multiple sclerosis
DE60130145T2 (de) * 2000-12-21 2008-05-15 Resuscitation Technologies, LLC, Santa Monica Stabile t3 zusammensetzungen und ihre anwendung
CN1325651C (zh) * 2001-05-24 2007-07-11 大连金威基因技术有限公司 人重组乙型干扰素的高效表达及其应用
CN1535724B (zh) * 2003-04-23 2012-09-05 北京金迪克生物技术研究所 重组人干扰素在制备预防严重性急性呼吸道综合征的药物的用途
PT2868315T (pt) * 2007-12-04 2017-09-04 Remedy Pharmaceuticals Inc Formulações melhoradas e métodos para liofilização e liofilizados assim produzidos
WO2022056233A1 (en) * 2020-09-12 2022-03-17 Academia Sinica Re-folded human serum albumin and use thereof for anti-tumor

Also Published As

Publication number Publication date
EA200001252A1 (ru) 2001-06-25
CA2333063A1 (en) 1999-12-09
CN1299285A (zh) 2001-06-13
JP2002516874A (ja) 2002-06-11
BR9815966A (pt) 2001-02-28
EP1082132A1 (en) 2001-03-14
EE200000694A (et) 2002-06-17
IS5732A (is) 2000-11-24
IL139933A0 (en) 2002-02-10
WO1999062542A1 (en) 1999-12-09
HUP0102241A2 (hu) 2001-10-28
NO20006022D0 (no) 2000-11-28
AU8822598A (en) 1999-12-20
NO20006022L (no) 2001-01-26
SK17762000A3 (sk) 2001-07-10
KR20010052454A (ko) 2001-06-25

Similar Documents

Publication Publication Date Title
DE69931507D1 (de) Interferon-beta fusionsproteine und deren verwendungen
PE20000560A1 (es) Uso de peg-ifn-alfa y ribavirina para el tratamiento de hepatitis c cronica
MXPA02006679A (es) Composicion farmaceutica.
DE69739665D1 (de) Isoliertes, dimerisches fibroblasten-aktivierendes protein alpha und anwendungen desselben
EP0695171A1 (en) GONADOTROPINE CONTAINING FREEZER DRIED DROPS
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
MX9707431A (es) Inhibidores de la proteina cinasa c.
BR0113666A (pt) Inibidores da protease peptidomimética
SG157952A1 (en) Small molecule antagonists of bcl-2 family proteins
ATE73321T1 (de) Zusammensetzung mit verzoegerter abgabe.
BR9811744A (pt) Conjugados contendo o homeodomìnio de antenapédia
EA200501699A1 (ru) Стабилизированные жидкие композиции интерферона, не содержащие человеческий сывороточный альбумин
MY122262A (en) Lh-rh peptide analogues their uses and pharmaceutical compositions containing them
TW200510528A (en) Polypeptide inducing apoptosis
DE69905170T2 (de) Thiazolopyrimidinderivate
IT1293778B1 (it) 1,4,7,10-tetraazabiciclo(8.2.2.)tetradecan-2 one, sua preparazione e suo uso per la preparazione di tetraazamacrocicli
TR199902334T2 (tr) Psikotik bozukluklarin tedavisi veya profilaksisi için mirtazapin ve antipsikotik ajanlarin yeni terapötik kombinasyonlari.
PT1149910E (pt) Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus
ES2117976T3 (es) Preparacion de derivados n-acetil neuraminicos.
SE9702680D0 (sv) New formulation
EE05213B1 (et) Lmfotoksiin- β retseptori (LT- β-R) blokeeriva agensi kasutamine ja LT- β-R-i blokeerivat agensit ning CD40L-i blokeerivat agensit sisaldav farmatseutiline kompositsioon
TR200003521T2 (tr) Yeniden-kombine-edilen insan interferonu beta-1a (IFN-beta-1a) formülasyonu.
TR200101493T2 (tr) Eletriptan hidrobromid monohidrat
TR200001724T2 (tr) 5-HT1F Agonistleri
BR9714376A (pt) Antagonistas de somatostatina